BioSpace News Archive

Harvard Pilgrim Health Care announced it is waiving member cost-sharing related to treatment for COVID-19.

Evaluate Ltd., the leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has completed an acquisition of Black Swan Analysis, a London-based consultancy specialising in asset valuations and epidemiology.

As part of its ongoing webinar series covering the impacts of the coronavirus disease 2019, DLA Piper is pleased to announce the following complimentary webinars for the week of March 30, 2020

Jobs Available in Indiana, Ohio, Tennessee, and Texas Caring for Individuals with Intellectual and Developmental Disabilities

Advance Receipts Program to help dentists; grants available to non-profits for projects related to coronavirus relief

UL leverages electrical and light technology expertise to support launch of ultraviolet-based technology solution for hospital and lab use [31-March-2020] MELVILLE, N.Y. , March 31, 2020 /PRNewswire/ -- UL , a leading global safety science company, today announced that PurpleSun , a healthcare technology company providing smart, light-based solutions for infection

Primmune Therapeutics announced that it has selected PRTX007 as its lead clinical development candidate for SARS-CoV-2 and for oncology indications.

LunellaTM LLC launched this week, a service that simplifies and makes sleep apnea diagnosis more accessible by giving consumers an at-home alternative to the traditional in-lab sleep study as a first line diagnostic tool.

Mimetogen Pharmaceuticals Inc. (“Mimetogen”), a clinical-stage biopharmaceutical company focused on the development of tavilermide, a first-in-class nerve growth factor (NGF) mimetic for the treatment of dry eye disease, today announced that it completed enrollment of its 600-patient MIM-728 Phase 3 clinical trial for tavilermide ophthalmic solution.

Agilent Technologies Inc. (NYSE: A) today announced the launch of the newest instrument in its Raman technology portfolio.